Eris Lifesciences Acquires India-Branded Formulation Business of Biocon Biologics for Rs 1,242 Crore
Eris Lifesciences acquires Biocon Biologics' India-branded formulation business, including insulin and oncology portfolios, for Rs 1,242 ...
Read moreDetails